General Info

Epinex is founded on the principle of applying expert scientific knowledge and proprietary technology for the benefit of users and the healthcare system. We are dedicated to advancing the technology of rapid diagnostics in order to provide easy access to critical diagnostic information at low cost. Our goal is to enhance patients' quality of life with diagnostic tests at the office, point of care, and over the counter to reduce costs, alleviate patient anxiety, enable earlier therapeutic intervention, and improve patient outcome. EPINEX PLATFORM TECHNOLOGY Epinex product research has developed a proprietary platform for rapid tests that applies existing immunoassay strips and biosensors to create unique quantitative diagnostic tests. These tests address critical healthcare areas by providing a type and quality of information unobtainable through existing testing methodologies. Potential International Distribution USPTO grants Epinex's patent for "rapid test for glycated albumin."This site is governed solely by applicable U.S laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the news section and the most recent SEC Fillings in the Investor section in order receive the most current information made available by Epinex Diagnostics, Inc Contact Us with any questions or search this site for more information.